Status:
COMPLETED
Intrauterine Insemination With Letrozole Versus in Natural Cycle
Lead Sponsor:
Peking University Third Hospital
Conditions:
Infertility
Intrauterine Insemination
Eligibility:
FEMALE
20+ years
Phase:
NA
Brief Summary
Rationale: Intrauterine insemination (IUI) is the treatment of first choice for couples with unexplained and mild male factor infertility in many countries, but it is controversial whether ovarian sti...
Eligibility Criteria
Inclusion
- Being diagnosed with unexplained or mild male subfertility
- At least one sided tubal patency, established according to local protocol
- Normal or mild impairment of semen quality defined as a TMSC of 3 million or more based on at least one semen analysis
Exclusion
- Woman with double sided tubal pathology
- Women with irregular cycles, PCOS or other endocrine disorders
- Impaired semen quality: pre-wash TMSC \<3 million.
Key Trial Info
Start Date :
March 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03455426
Start Date
March 15 2018
End Date
December 31 2019
Last Update
February 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University third Hospital
Beijing, Beijing Municipality, China, 100191